Swiss pharma giant Novartis (NOVN: VX) was trading 3% lower at lunchtime on Wednesday after presenting its fourth-quarter and full-year financial results. 2 February 2022
Calling MIG a leading German venture capital (VC) investment firm and one with a focus on life sciences and deep tech companies, might not do justice to the key 27 January 2022
California-based Maze Therapeutics, a company seeking to translate genetic insights into new precision medicines, has announced a $190 million financing. 11 January 2022
Research from British online pharmacy Chemist4U has revealed some insights on the current state of prescriptions in England, including the most prescribed medic 22 December 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.